Loading...
ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia
Matched-related bone marrow transplantation (BMT) may cure >80% of low-risk children with severe thalassemia (ST). Very long-term follow-up studies have shown how the standard busulfan-cyclophosphamide (BuCy) regimen may be associated with normalization of health-related quality of life, no secon...
Na minha lista:
| Udgivet i: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5727808/ https://ncbi.nlm.nih.gov/pubmed/29296723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2016004119 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|